Smarter Analyst |
MEI Pharma (MEIP), Helsinn Enter Development and Commercialization Agreement for Pracinostat
StreetInsider.com Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here. Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the ... Helsinn Teams Up with MEI Pharma to Develop AML Compound Pracinostat MEI Pharma Partners with Helsinn on Drug with Potential $464M Payoff MEI Pharma lands major deal for cancer drug Pracinostat |
MEI Pharma (MEIP), Helsinn Enter Development and Commercialization Agreement for Pracinostat - StreetInsider.com
Read More
0 Response to "MEI Pharma (MEIP), Helsinn Enter Development and Commercialization Agreement for Pracinostat - StreetInsider.com"
Post a Comment